ADI to Participate in the International Zika Summit 2016

An International Zika Summit has been organized to bring together scientists and public health professionals around the world working on Zika. The speed and extent of this outbreak, which the WHO declared a Public Health Emergency of International Concern, requires open collaborations between researchers, the public health community and the public. This meeting will provide a venue for open such discussions.  ADI will be participating in this summit and present the availability of kits and reagents that the research community could use for developing countermeasures against the spread of this disease.  For further details about the summit, please visit http://www.zikasummit2016.org/

Zika Virus Detection in Humans and Animals Using ELISA Kits

San Antonio, Texas-based biotech company Alpha Diagnostic International, Inc (ADI) has developed several ELISA test kits for the detection of major Zika viral protein antibodies (Capsid, Envelope, prM, and NS1). The ELISA kits are available for humans as well as monkeys and mice that can be readily used in ongoing research and vaccine development projects on animal models of disease. 



Read the entire press release at http://www.prweb.com/releases/2016/03/prweb13244687.htm

ADI participates in NIH-NIAID sponsored meeting on Zika virus

The Zika virus epidemic that originated in other parts of the world has now made its way into US and has become a critically important research area for development of diagnostics, vaccines and therapeutics.  As a new disease that shows all the signs of becoming a global epidemic, there is an urgent need for reagents and tools that are necessary for developing methods to combat this disease.  The first Zika Virus conference (Zika Virus in the Americas: An HHS Expert Consultation to Accelerate the Development of Countermeasures) was recently concluded at North Bethesda in Maryland (Mar 28 - 29, 2016).  At this conference, Dr. Masarrat Ali had an opportunity to interact with several members of the research community to discuss and present reagents that are immediately available from ADI and understand other needs of the community in order to develop countermeasures in a timely manner.  ADI is the first company to develop reagents designed to help researchers across the world who are engaged in Zika virus research.  For additional details on these reagents, please visit http://4adi.com/commerce/catalog/srhkeyword.cz

Welcome to Alpha Diagnostic International, Inc.- Home of TruStrip Products

Alpha Diagnostic Internation, Inc. (ADI) is a privately held, U.S. biotechnology company headquartered in San Antonio, Texas.  ADI develops, manufactures, and supplies novel diagnostic and quality control reagents and test kits for use in basic biological and disease research in humans and animals.  An important mission of ADI is to develop and supply diagnostic and validating solutions for promoting global health through improved vaccine therapeutics and mitigating the spread of human and animal diseases. For additional details, please visit: http://www.4adi.com